These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35087193)

  • 1. Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment.
    Eirefelt S; Stahlhut M; Svitacheva N; Carnerup MA; Da Rosa JMC; Ewald DA; Marstrand TT; Krogh-Madsen M; Dünstl G; Dack KN; Ollerstam A; Norsgaard H
    Sci Rep; 2022 Jan; 12(1):1501. PubMed ID: 35087193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
    Dack KN; Johnson PS; Henriksson K; Eirefelt S; Carnerup MA; Stahlhut M; Ollerstam AK
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127402. PubMed ID: 32738970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
    Maubec E; Laouénan C; Deschamps L; Nguyen VT; Scheer-Senyarich I; Wackenheim-Jacobs AC; Steff M; Duhamel S; Tubiana S; Brahimi N; Leclerc-Mercier S; Crickx B; Perret C; Aractingi S; Escoubet B; Duval X; Arnaud P; Jaisser F; Mentré F; Farman N
    J Invest Dermatol; 2015 Jul; 135(7):1781-1789. PubMed ID: 25668238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-dependent transcription in skin requires epidermal expression of the glucocorticoid receptor and is modulated by the mineralocorticoid receptor.
    Sevilla LM; Bigas J; Chiner-Oms Á; Comas I; Sentandreu V; Pérez P
    Sci Rep; 2020 Nov; 10(1):18954. PubMed ID: 33144612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
    Sevilla LM; Pérez P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
    Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
    Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
    Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
    J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of RU 486 on the atrophogenic and antiinflammatory effects of glucocorticoids in skin.
    Iwasaki K; Mishima E; Miura M; Sakai N; Shimao S
    J Dermatol Sci; 1995 Sep; 10(2):151-8. PubMed ID: 8534614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
    Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
    Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis.
    Røpke MA; Alonso C; Jung S; Norsgaard H; Richter C; Darvin ME; Litman T; Vogt A; Lademann J; Blume-Peytavi U; Kottner J
    J Dermatol Sci; 2017 Dec; 88(3):330-338. PubMed ID: 28911799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEGRAs: a novel class of anti-inflammatory compounds.
    Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
    Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
    Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
    J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
    Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
    Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-Epithelialization of Pathological Cutaneous Wounds Is Improved by Local Mineralocorticoid Receptor Antagonism.
    Nguyen VT; Farman N; Maubec E; Nassar D; Desposito D; Waeckel L; Aractingi S; Jaisser F
    J Invest Dermatol; 2016 Oct; 136(10):2080-2089. PubMed ID: 27262545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mineralocorticoid receptor in skin disease.
    Pérez P
    Br J Pharmacol; 2022 Jul; 179(13):3178-3189. PubMed ID: 34788475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model.
    Zöller NN; Kippenberger S; Thaçi D; Mewes K; Spiegel M; Sättler A; Schultz M; Bereiter-Hahn J; Kaufmann R; Bernd A
    Toxicol In Vitro; 2008 Apr; 22(3):747-59. PubMed ID: 18249522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
    Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in the induction of mono-oxygenase activity in mouse skin by topical clobetasol propionate: evidence of a role for the hr locus.
    Finnen MJ; Herdman ML; Shuster S
    J Steroid Biochem; 1985 Oct; 23(4):431-5. PubMed ID: 2999513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.